Egyptian entrepreneur Hashem Abdou raised USD 4.6 mn in seed and pre-seed funding for his New York-based healthtech startup Oasys Health, according to a statement from the company. The seed round was led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, while the pre-seed round was backed by 1984 Ventures.

While the funding headline is being read in the Western business press as a good-sized health-AI seed round, the story for our readers is the export of Egyptian tech expertise. Abdou, who worked at Egyptian fintech heavyweights Khazna and Klivvr, is now building what the company describes as “the operating system for modern mental healthcare.”

Abdou credits his years in the Egyptian startup scene with providing him with the resilience necessary to navigate the US healthcare sector. “Building in Egypt forces you to develop a high tolerance for ambiguity, resource constraints, and regulatory complexity early on. You learn to be scrappy, relationship-driven, and resilient,” Abdou tells EnterpriseAM. “Those instincts translated directly to building Oasys in the US (especially in healthcare), where progress is slow, trust is earned, and systems are deeply entrenched.”

Oasys represents a shift away from consumer wellness apps and toward a system that brings clinical rigor to mental health workflows. “For decades, therapy has been a subjective, session-based practice built on intuition and recall rather than measurable evidence. Now, for the first time, we have the tools to change that,” Abdou said in the statement.

“Advances in AI allow us to extract insights from unstructured clinical data … and Oasys has built the connective tissue to tie it all together,” Abdou added. By tying together practice management — billing, scheduling, and documentation — with real-time physiological data from wearables like the Apple Watch and Oura Ring, Oasys says it can save clinicians 10+ hours each week on administrative tasks, reduce burnout and inefficiencies, open up new revenue streams from remote data collection, and provide patients with “more personalized, preventive, and measurable care that extends beyond traditional sessions.”

Unlike healthtech startups that focus on a single niche, Oasys aims to rebuild the core infrastructure for behavioral health. “Legacy systems were never designed for longitudinal, behavioral, and real-world data. In that sense, we’re not trying to be a bolt-on or a thin layer, we’re rebuilding the core infrastructure for this specialty from first principles,” Abdou said.

Looking ahead, the company sees its data backbone applying to a wide range of chronic conditions. “Mental health is where we’re starting, but the underlying problem is broader: chronic conditions require continuous, real-world data and better decision infrastructure,” Abdou said. “Five years from now, I expect Oasys to still be deeply rooted in mental health, but also powering care models wherever behavior, physiology, and long-term outcomes intersect.”

While currently focused on the US, Abdou views the MENA region as a major long-term opportunity. “Mental health in MENA is at an inflection point: there’s growing awareness, a younger generation that’s far more open to care, and a real opportunity to reshape how mental health is understood and delivered,” he said.

What’s next? The company is working now with 25 health clinics supporting thousands of patients and aims to have more than 1k enterprise-scale organizations on its books by the end of 2026. Later this year, the company will also launch an outcomes measurement framework, providing the standardized data necessary to help prove therapy effectiveness to ins. providers.

(** Tap or click the headline above to read this story with all of the links to our background as well as external sources.)

Tags: